874 fundamentals
An in-depth look to GUANGZHOU BAIYUNSHAN PHARMACEUTICAL operating, investing, and financing activities
874 free cash flow for Q1 24 is -3.73 B HKD. For 2023, 874 free cash flow was 3.16 B HKD and operating cash flow was 4.96 B HKD.
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: HKD
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
TTM